Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis

Dupilumab is the first biological treatment approved for moderate-to-severe atopic dermatitis (AD). Efficacy and safety have been demonstrated in clinical trials, but real-life data is still limited. The objective of this study was to retrospectively evaluate Dupilumab treatment in AD patients in a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Med
Hauptverfasser: Quint, Tamara, Brunner, Patrick M., Sinz, Christoph, Steiner, Irene, Ristl, Robin, Vigl, Kornelia, Kimeswenger, Susanne, Neubauer, Katharina, Pirkhammer, Detlev, Zikeli, Martin, Hoetzenecker, Wolfram, Reider, Norbert, Bangert, Christine
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7230957/
https://ncbi.nlm.nih.gov/pubmed/32344789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9041241
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge